On March 31, 2026, the Company implemented a reorganization of its operations including a reduction of the Company’s current global workforce by approximately 146 employees, or 10% of the Company’s global workforce at the time (the “March 2026 Reorganization”). As a result, in the first quarter of fiscal year 2027, the Company incurred $7.3 million of employee severance, termination and employment-related exit costs and $1.0 million of facility exit costs.

The following table summarizes the charges related to the March 2026 Reorganization by line item within the Company’s condensed consolidated statements of operations for the six months ended July 31, 2026:


	Severance and employment-related termination costs		Facility and other contract terminations		Total
	(in thousands)
Cost of revenue	$	730	$	—	$	730
Research and development	4,122		—		4,122
Sales and marketing	1,681		—		1,681
General and administrative	786		1,040		1,826
Total	$	7,319	$	1,040	$	8,359

As of July 31, 2026, $2.5 million in restructuring-related liabilities remained in accrued and other current liabilities in the condensed consolidated balance sheets. As of January 31, 2026, restructuring liabilities related to the September 2023 reorganization of $0.1 million remained in accrued and other current liabilities in the condensed consolidated balance sheets.

On July 29, 2026, the Company implemented a reorganization of its operations including a reduction of the Company’s current global workforce of approximately 127 employees, or 10% of the Company’s global workforce at the time (the “July 2026 Reorganization”). As a result, during the three and six months ended July 31, 2026 the Company incurred $5.7 million of employee severance, termination and employment-related exit costs and $0.7 million of facility exit costs.

The following table summarizes the charges related to the July 2026 Reorganization by line item within the Company’s condensed consolidated statements of operations for the six months ended July 31, 2026:


	Severance and employment-related termination costs		Facility and other contract terminations		Total
	(in thousands)
Cost of revenue	$	624	$	—	$	624
Research and development	2,210		—		2,210
Sales and marketing	1,509		—		1,509
General and administrative	1,333		723		2,056
Total	$	5,676	$	723	$	6,399

As of July 31, 2026, $5.3 million in restructuring-related liabilities remained in accrued and other current liabilities in the condensed consolidated balance sheets.